Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Contineum Therapeutics (CTNM) Preferred Shares Issued (2023)

Contineum Therapeutics (CTNM) has 1 years of Preferred Shares Issued data on record, last reported at $10.2 million in Q3 2023.

  • For Q3 2023, Preferred Shares Issued changed N/A year-over-year to $10.2 million; the TTM value through Dec 2024 reached $10.2 million, changed N/A, while the annual FY2023 figure was $60.1 million, N/A changed from the prior year.
  • Preferred Shares Issued reached $10.2 million in Q3 2023 per CTNM's latest filing, down from $27.9 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $27.9 million in Q2 2023 and bottomed at $10.2 million in Q3 2023.